Case report: Albendazole associated psychosis.
| Autor: | Doughty B, Tumey LN, Williams K |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The mental health clinician [Ment Health Clin] 2019 Nov 27; Vol. 9 (6), pp. 397-400. Date of Electronic Publication: 2019 Nov 27 (Print Publication: 2019). |
| DOI: | 10.9740/mhc.2019.11.397 |
| Abstrakt: | Introduction: The association of psychosis with albendazole monotherapy has not been established in current literature. Case Report: We present the first reported case of acute psychosis associated with albendazole. Upon cessation of the agent and the introduction of aripiprazole, the patient's psychosis remitted, and the patient did not present for acute treatment in the months to follow. Discussion/conclusion: The temporal relationship and laboratory data support albendazole's role in leading to the aforementioned toxicity. Such reactions, although rare, can drastically impact patient care and may warrant increased provider consideration when choosing to prescribe albendazole. Competing Interests: Disclosures: The authors have nothing to disclose. (© 2019 CPNP. The Mental Health Clinician is a publication of the College of Psychiatric and Neurologic Pharmacists.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|